According to Market Research Future (MRFR), the global poultry vaccines market size valued USD 13,35.81 Million in 2017, which is expected to appreciate at 7.25% over CAGR during the assessment period (2018-2023). The global poultry vaccines market is witnessing rapid growth. Market growth of poultry vaccines attributes to the rising prevalence of myriads of poultry diseases, including Marek’s disease. Besides, the outbreak of various viruses, such as Newcastle disease (ND), that causes a severely contagious disease affecting all species of birds, Poulvac Procerta HVT-ND, and others drive the poultry vaccines growth.
There has been a spurting rise in the demand for protection against a challenge with a velogenic (virulent) ND virus and a velogenic ND virus challenge. Also, poultry vaccines in specific-pathogen-free birds, regardless of vaccine administered in ovo or subcutaneously, have been growing significantly. The new immune complex vaccine against Gumboro disease is registering rapid sales. Moreover, the rising consumption of Poulvac Procerta HVT-ND vaccines of turkey (HVT), an avirulent turkey virus capable of replication in chickens, escalates the poultry vaccines growth.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/7515
The report defines all significant poultry vaccines market aspects, adding expert opinion on current and historical data. Further, the report also covers investment opportunities, market statistics, growing competition analysis, gross margins, and top business strategies. MRFR assesses the rapidly changing market scenario, including the impact of pre and post coronavirus crises.
The poultry vaccines market witnesses a huge demand for live coccidiosis vaccine against avian coccidiosis in poultry, such as E. brunetti, E. acervulina, E. maxima, E. tenella, and E. necatrix. Also, sales of vaccine-mediated protection against Campylobacter-associated enteric disease are rising continually. The smart vaccination concept for poultry farming introduced some five years ago has become a prevailing market trend now.
The development of Eimeria vaccine that enables long life-cycle birds to prevent avian coccidiosis is another trend that has been driving a significant market share. Also, the emergence of various advanced vaccination devices that enables spray administration of vaccines has increased the uptake of poultry vaccines.
Technology advances have brought about innovations such as RFID chip inserted into the label, which contains all the information related to the vaccine. On the other hand, the high cost and lack of awareness associated with poultry vaccines are the key factors expected to hamper the market growth. Also, unaffordable veterinary services impede the growth of the poultry vaccines market in underdeveloped and developing regions.
Nevertheless, rising demand for animal protein and increasing focus on food safety would support the market growth throughout the predicted period. Additionally, increasing awareness about animal vaccination, growth in the poultry population, and improvement in government initiatives would contribute to the market growth.
Poultry Vaccines Market Segmentation
By Diseases, the global poultry vaccines market is segmented into Infectious bronchitis, Avian Influenza, Marek’s Disease, Newcastle Disease, and others.
By Technology, the global poultry vaccines market is segmented into Toxoid Vaccines, Recombinant Vaccines, Inactivated Vaccines, Live Attenuated Vaccines (LAV), and others.
By Dosage Form, the global poultry vaccines market is segmented into Vaccines, Liquid Vaccines, Freeze Dried Vaccines, and others.
Poultry Vaccines Market Regional Outlook
North America leads the global poultry vaccines market. The largest market share of poultry vaccines attributes to the awareness about the importance of prevention of animal-to-human transmission of diseases and safe animal food supply. Besides, rising investment in research and development of poultry vaccines increase the size of the regional market.
Moreover, high expenditure on animal care and the presence of veterinary hospitals foster the market growth in the region. Additionally, favorable reimbursement policies fuel the growth of the regional market. The North American poultry vaccines market is projected to retain its dominance over the overall market throughout the forecast period.
Europe stands second in the global poultry vaccines market, driven by the increasing government support for R&D, increasing production of poultry care products, and improved reforms of poultry practices in the region. Additionally, a spurting rise in the veterinary vaccine market and animal vaccination market impact the poultry vaccines industry positively.
Furthermore, the availability of types of poultry vaccines and advanced poultry vaccination methods in the region drives a considerable market share. The European poultry vaccines market is expected to create a substantial revenue pocket over the review period.
The Asia Pacific poultry vaccines market is an emerging market. Factors such as the penetration of the veterinary sector and surging numbers of private veterinary clinics boost the regional poultry vaccines growth. Also, increasing awareness about animal welfare in China, India, and Australia influence the growth of the regional poultry vaccines market. Moreover, the growing vaccine manufacturing base and increasing awareness of safe animal food supply bolster the market growth. The APAC poultry vaccines market is anticipated to remain the fastest-growing poultry vaccines market during the assessment period.
Poultry Vaccines Market Competitive Landscape
Highly competitive, the poultry vaccines market appears fragmented due to the presence of several well-established players. The market is almost entirely generic, which is further constraining its value growth. Lack of safe, effective vaccines against multitudes of diseases is another constraint. However, the emergence of smart vaccines is likely to gain a large and faster market uptake.
Poultry Vaccines Market Major Players:
Players leading the global poultry vaccines market include Elanco, Boehringer Ingelheim, MSD & Co., Ceva Animal Health Inc., Zoetis Inc, Phibro Animal Health Corporation, Hipra, Virbac, Venkys, Anicon GmbH, and Biovet, among others.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/poultry-vaccines-market-7515
Poultry Vaccines Industry/ Innovation/ Related News:
Zoetis Products (the US), announced the further expansion of its poultry vaccine portfolio with the introduction of a vectored recombinant vaccine – Poulvac®Procerta™HVT-ND. The new poultry vaccine protects broiler chickens against Newcastle and Marek’s disease viruses. The vaccine was developed using improved molecular techniques to deliver a highly effective immune response, with the competitive onset of immunity.
NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar